Molecular interactions between dipeptides, drugs and the human intestinal H+-oligopeptide cotransporter hPEPT1

Journal of Physiology

Volumn 574, Issue 1, 2006, Pages 149-166

  Sala Rabanal, Monica ^a   Loo, Donald D F ^a   Hirayama, Bruce A ^a   Turk, Eric ^a   Wright, Ernest M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINOLEVULINIC ACID; AMOXICILLIN; AMPICILLIN; ANTINEOPLASTIC AGENT; ASPARAGINE; BESTATIN; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DIPEPTIDE DERIVATIVE; GENTAMICIN; GLYCINE; GLYCYLSARCOSINE; N ACETYLASPARTYLGLUTAMIC ACID; NEUROPEPTIDE; PENICILLIN DERIVATIVE; PENICILLIN G SODIUM; PEPTIDE TRANSPORTER 1; PROTON; SERINE; STREPTOMYCIN SULFATE; TRACER;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BINDING; DRUG TRANSPORT; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; ENZYME KINETICS; ENZYME METABOLISM; ENZYME SUBSTRATE; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OOCYTE; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEADY STATE; TURNOVER TIME; WILD TYPE; XENOPUS; BINDING AFFINITY; DRUG BIOAVAILABILITY; MATHEMATICAL MODEL; MOLECULAR RECOGNITION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN TRANSPORT;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA-LACTAMS; BINDING SITES; CELLS, CULTURED; COMPUTER SIMULATION; DIPEPTIDES; HUMANS; ION CHANNEL GATING; MODELS, BIOLOGICAL; MODELS, CHEMICAL; OOCYTES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS; XENOPUS LAEVIS;

EID: 33745192344     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.107904     Document Type: Article

References (39)

1. Anderle P, Nielsen CU, Pinsonneault J, Krog PL, Brodin B & Sadee W (2006). Genetic Variants of the human dipeptide transporter PEPT1. J Pharmacol Exp Ther 316, 636-646.
2. Boll M, Markovich D, Weber WM, Korte H, Daniel H & Murer H (1994). Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, β-lactam antibiotics and ACE-inhibitors. Pflugers Arch 429, 146-149.
3. +-hexose cotransporter (STP1) from Arabidopsis thaliana expressed in Xenopus oocytes. J Biol Chem 269, 20417 -20424.
4. +-peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res 16, 55-61.
5. Daniel H (2004). Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66, 361-384.
6. Daniel H & Kottra G (2004). The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch 447, 610-618.
7. Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM & Koepsell H (2003). A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci U S A 100, 11753-11758.
8. Doring F, Walter J, Will J, Focking M, Boll M, Amasheh S, Clauss W & Daniel H (1998). Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest 101, 2761-2767.
9. -symporter. Mechanism, stoichiometry and specificity. J Biol Chem 272, 27230-27238.
10. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF & Hediger MA (1994). Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368, 563-566.
11. +-Pi cotransporters. Am J Physiol 276 F644-F649.
12. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V & Leibach FH (1995). Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J Biol Chem 270, 25672-25677.
13. Ganapathy ME, Huang W, Wang H, Ganapathy V & Leibach FH (1998). Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 246, 470-475.
14. Ganapathy ME, Prasad PD, Mackenzie B, Ganapathy V & Leibach FH (1997). Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2. Biochim Biophys Acta 1324, 296-308.
15. + -glucose cotransporter in Xenopus laevis oocytes. Proc Natl Acad Sci U S A 84, 2634-2637.
16. Hu M, Subramanian P, Mosberg HI & Amidon GL (1989). Use of the peptide carrier system to improve the intestinal absorption of 1-α-methyldopa: Carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of 1-α-methyldopa. Pharm Res 6, 66-70.
17. +-coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes. J Pharmacol Exp Ther 260, 482-486.
18. +-coupled peptide transport via human PEPT1. J Physiol 565, 429-439.
19. Kottra G & Daniel H (2001). Bidirectional electrogenic transport of peptides by the proton-coupled carrier PEPT1 in Xenopus laevis oocytes: its asymmetry and symmetry. J Physiol 536, 495-503.
20. + -peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 270, 6456-6463.
21. + -coupled cotransporters GAT1 and SGLT1. J Biol Chem 275, 37414-37422.
22. +-glucose cotransporter. Proc Natl Acad Sci U S A 90, 5767 -5771.
23. + and glucose transport. Proc Natl Acad Sci U S A 95, 7789-7794.
24. + -coupled oligopeptide transporter hPEPT1. J Biol Chem 271, 5430-5437.
25. +-glucose cotransporter SGLT2 reveal a common mechanism for SGLT1 and SGLT2. J Biol Chem 271, 32678-32683.
26. +-glucose cotransporter (SGLT1) currents and fluxes. J Membr Biol 162, 101-106.
27. +-glucose cotransporter. I. Voltage-clamp studies. J Membr Biol 125, 49-62.
28. +-glucose cotransporter: II. A transport model under nonrapid equilibrium conditions. J Membr Biol 125, 63-79.
29. Rubio-Aliaga I & Daniel H (2002). Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol Sci 23, 434-440.
30. Sadée W (1999). Pharmacogenomics. BMJ 319, 1286-1289.
31. Soragna A, Bossi E, Giovannardi S, Pisani R & Peres A (2005). Relations between substrate affinities and charge equilibration rates in the rat GABA cotransporter GAT1. J Physiol 562, 333-345.
32. Temple CS & Boyd CA (1998). Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: A functional analysis using ACE inhibitors to determine the isoform of the transporter. Biochim Biophys Acta 1373, 277-281.
33. Terada T, Saito H, Mukai M & Inui K (1997). Recognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. Am J Physiol 273, F706-F711.
34. Terada T, Sawada K, Irie M, Saito H, Hashimoto Y & Inui K (2000). Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2. Pflugers Arch 440, 679-684.
35. Wang H, Fei YJ, Ganapathy V & Leibach FH (1998). Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain. Am J Physiol 275, C967-C975.
36. Wenzel U, Gebert I, Weintraut H, Weber WM, Clauss W & Daniel H (1996). Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. J Pharmacol Exp Ther 277, 831-839.
37. - -dependent neurotransmitter transporters. Nature 437, 215-223.
38. Zhang EY, Fu DJ, Pak YA, Stewart T, Mukhopadhyay N, Wrighton SA & Hillgren KM (2004). Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: Implications for the functional role of Pro586. J Pharmacol Exp Ther 310, 437-445.
39. Zhu T, Chen XZ, Steel A, Hediger MA & Smith DE (2000). Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharm Res 17, 526-532.